Kroger (KR) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
6 Jan, 2026Executive summary
Fourth quarter identical sales without fuel grew 2.4% year-over-year; full-year growth was 1.5%.
Digital sales rose 11% in Q4 and 10% for the year, surpassing $13B annually.
Adjusted FIFO operating profit was $1.17B for Q4 and $4.7B for the year.
Adjusted EPS was $1.14 for Q4 (flat year-over-year) and $4.47 for the year (down 2%).
Launched $5B accelerated share repurchase program under $7.5B authorization.
Financial highlights
Q4 sales were $34.3B, down from $37.1B last year due to the prior year’s 53rd week and pharmacy sale; sales up 2.6% excluding these.
Full-year sales were $147.1B, down from $150.0B.
Q4 gross margin improved to 22.7% from 22.3% year-over-year; full-year gross margin rose to 22.3% from 21.8%.
Q4 net income attributable to Kroger was $634M; full-year net income was $2.67B.
Adjusted free cash flow for the year was $2.5B, down from $3.2B in 2023.
Outlook and guidance
2025 guidance: identical sales without fuel growth of 2%-3%, adjusted FIFO operating profit of $4.7B-$4.9B, and adjusted EPS of $4.60-$4.80.
Free cash flow expected at $2.8B–$3.0B; capital expenditures of $3.6B–$3.8B; tax rate of 23%.
LIFO charge expected to be ~$130M in 2025; inflation forecasted at 1.5%-2.5%.
Quarterly cadence: Q1 EPS similar to last year, Q2-Q4 above prior year.
Latest events from Kroger
- Strong sales, margin gains, and eCommerce growth, with 2026 guidance signaling continued momentum.KR
Q4 20265 Mar 2026 - Dividend raised, strong sales, and all shareholder proposals defeated at the annual meeting.KR
AGM 20253 Feb 2026 - Q1 sales and digital growth offset profit declines as guidance and merger focus remain.KR
Q1 20253 Feb 2026 - Q2 2024 delivered 1.2% sales growth, $0.93 EPS, and strong digital gains amid merger progress.KR
Q2 202520 Jan 2026 - Q3 digital and pharmacy gains offset lower fuel sales; Albertsons merger terminated, $7.5B buyback set.KR
Q3 202511 Jan 2026 - Q2 2025 delivered strong sales, margin growth, and raised guidance, led by eCommerce and pharmacy.KR
Q2 202615 Dec 2025 - Adjusted EPS rose 7% to $1.05, but a $2.6B impairment drove a net loss.KR
Q3 202612 Dec 2025 - Board recommends director elections, pay approval, auditor ratification, and opposes all shareholder proposals.KR
Proxy Filing1 Dec 2025 - Virtual meeting to vote on directors, pay, auditor, and key proposals; board supports all nominees.KR
Proxy Filing1 Dec 2025